baber/WOPTO huggingface dataset:
Patent FI-862113-A0 (FI)
Inventor: SIMENSEN PER ARNE
IPC: E02B17/00
Filed: 1986-05-20
Abstract: PCT No. PCT/NO85/00056 Sec. 371 Date May 20, 1986 Sec. 102(e) Date May 20, 1986 PCT Filed Sep. 18, 1985 PCT Pub. No. WO86/01752 PCT Pub. Date Mar. 27, 1986.A method for providing a tubular node in framework truss structures, such as offshore platforms for oil drilling and production activities of the type consisting of interconnected legs and braces of steel tube elements. For formation of the transition between leg and brace in the node is utilized a blank of rolled plate steel, which is given the desired curved shape corresponding to the curvature of the leg. The blank is pressed or extruded in a suitable press tool formed with an outwardly extending brace stub at the desired angle, which brace stub is designed for welding to a complementary brace tubing in the framework. Thereafter, the blank with the brace stub is welded into the leg proper and constitutes a wall segment of the leg in the node.
Patent FI-871504-A0 (FI)
Inventor: SCHROEDER JORIS
IPC: B66B1/46
Filed: 1987-04-07
Abstract: A group control assigns elevator cars to floor calls optimized in such a manner, that minimal waiting times result and the elevating capacity is increased. A computing device provided for each elevator calculates at every floor a sum proportional to the time losses of the waiting passengers from the distance between the floor and the car position as indicated by a selector, the intermediate stops to be expected within the distance and the instantaneous car load. By means of call registering devices in the form of ten key keyboards at the floors, it is possible to enter calls for destination floors, so that at the time of calculation, the floor calls and the car calls are available simultaneously. The calculated lost time sum, also called servicing costs, is stored in a cost memory provided for each elevator. During a cost comparison cycle, the servicing costs of all elevators are compared with each other by way of a cost comparison device where in each case an assignment instruction can be stored in an assignment memory of the elevator with the lowest servicing costs which instruction designates that floor to which the respective car is optimally assigned in time.
Patent FI-893702-A0 (FI)
Inventor: FLEER REINHARD
IPC: C12N1/19
Filed: 1989-08-04
Abstract: Microbiological method for the preparation of human serum albumin and other heterologous (non-yeast) proteins by growing a yeast, especially of the genus Kluyveromyces, modified by the use of recombinant DNA techniques.
Patent FI-894113-A0 (FI)
Inventor: CONAWAY LAWRENCE
IPC: C07D277/74
Filed: 1989-09-01
Abstract: A process for the manufacture of 2-thiocyanomethylthiobenzothiazole. 2-Chloromethylthiobenzothiazole is reacted, in the presence of at least one glycol ether as a solvent for the reaction, with either an alkali metal or an ammonium thiocyanate at a temperature and for a time sufficient to produce the 2-thiocyanomethylthiobenzothiazole.
Patent FI-894778-A0 (FI)
Inventor: HODGE STEPHEN ROBERT
IPC: C11D3/395
Filed: 1989-10-09
Abstract: The present invention relates to a detergent composition in aqueous solution comprising:   (i) a surfactant selected from anionic, nonionic, zwitterionic and cationic surfactants and mixtures thereof, (ii) a precursor compound capable of giving a rise to a peroxygen compound in the presence of water, (iii) a bleach activator capable of enhancing the bleaching activity of the peroxygen compound so formed,   (iv) a suds suppressing agent and   (v) a detergent builder, characterised in that the bleach activator comprises one or more cyclic tertiary nitrogen compounds of a defined generic formula, said activator being at least partially soluble in water. The claimed bleach activators show bleaching activity at relatively low temperatures.
Patent FI-904229-A0 (FI)
Inventor: SCHWARTZ MICHAL
IPC: A61P43/00
Filed: 1990-08-27
Abstract: A novel oligodendrocyte cytotoxic factor, salts, precursors, fragments and homologs thereof and functional derivatives of said factor or of its fragments or homologs, are selectively toxic to the oligodendrocyte lineage. Pharmaceutical compositions comprising them are useful for inducing regeneration of injured nerves of the central nervous system in mammals.
Patent FI-913844-A0 (FI)
Inventor: KOTA GEORGE M
IPC: B01D5/00
Filed: 1991-08-14
Abstract: Noxious flue gases issuing from a combustion process are treated by a chemical - mechanical process wherein initial condensation of at least a portion of the water vapour present, and intimate mixing of this condensation with a high concentration of alkali and/or alkali salts and the residual gases, results in scrubbing of the flue gases. A major portion of the resulting product is removed from the residual flue gas. The loss in thermal energy of the flue gases in the initial stage of scrubbing may be subsequently compensated by supplementary heating. Additional treatment includes the spraying of a basic substance such as limewash in dispersed relation into the residual flue gases, to eliminate the acidic content of the gases, and to regulate the amount of carbon dioxide in the atmosphere.
Patent FI-914410-A0 (FI)
Inventor: DINERSTEIN ROBERT JOSEPH
IPC: C07D233/70
Filed: 1991-09-19
Abstract: This invention relates to 1-phenyl-3-aryl-2-propyne-1-ones and pharmaceutical compositions containing these compounds as active ingredients useful as calcium uptake inhibitors in leukocytes and the process of their preparation.
Patent FI-931262-A0 (FI)
Inventor: BRANDES BERND
IPC: G01N27/00
Filed: 1993-03-22
Abstract: A method and apparatus is provided for monitoring a variable in a system. Actual values of the variables are sensed to produce sensed values. An initial threshold is set below an initially sensed value by a predetermined difference. Thereafter, the threshold is selectively maintained constant and adjusted to follow below the sensed values by a difference which is a function of the sensed values if the sensed values remain constant or increase, with the threshold remaining constant if the sensed values decreases. The threshold is compared with the sensed values and an indication of an unsatisfactory quality is provided if the sensed values fall below the threshold.
Patent FI-942762-A0 (FI)
Inventor: SERENO DANIELE
IPC: G10L19/06
Filed: 1994-06-10
Abstract: A method of and a device for speech signal digital coding are described, where spectral parameters are quantized at each frame in order to exploit the actual correlation inside a frame or between contiguous frames. The quantization devices (DQ) recognize strongly correlated signal periods by using a first set of indexes (j1), representing the parameters and provided by the spectral analysis circuits (ABT, ALT), and in these periods they convert the same indexes into a second set of indexes (j4) which can be coded with a lower number of bits and which is inserted into the coded signal in place of the first set. <IMAGE>
Patent FI-951098-A0 (FI)
Inventor: CHAWLA BRINDRA PAUL SINGH
IPC: A61J7/00
Filed: 1995-03-09
Abstract: PCT No. PCT/GB93/01909 Sec. 371 Date Mar. 27, 1995 Sec. 102(e) Date Mar. 27, 1995 PCT Filed Sep. 9, 1993 PCT Pub. No. WO94/05560 PCT Pub. Date Mar. 17, 1994A medicament pack (1) comprising a base member (2) having a plurality of blisters (3) formed therein, each blister (3) being adapted to accommodate a medicament containing capsule (4), each capsule (4) being provided with at least one aperture (5) to permit medicament to be dispensed therefrom, wherein the base member (2) comprises sealing surfaces (6) adapted to seal the apertures (5).
Patent FI-952293-A0 (FI)
Inventor: CHEUNG NELSON
IPC: F16C19/16
Filed: 1995-05-11
Abstract: A rotary apparatus (10), such as a pneumatic motor, comprises an end plate (20) having a race cavity (22), a main rotor (30) with a stub shaft (32) extending from one end, and a bearing (40), which includes an outer race (42) seated in the race cavity (22) and an inner race (44) having a central bore (50). The stub shaft (32) is fitted into the central bore (50) with a frictional fit. The threaded shank (62) of a screw (60) is threaded into a threaded socket (80) in the stub shaft (32) and is used to draw the stub shaft (32) into the central bore (50) with a washer (70) bearing against a head (64) of the screw, and against the inner race (44), whereby a controlled gap (g) can be provided between an outer surface (36) of the main rotor (30) and an inner surface (26) of the end plate (20). <IMAGE>
Patent AP-8500009-A0 (AP)
Title: New phenoxypropanolamine salts and pharmaceutical preparations thereof.
Inventor: SJOGREN JOHN ALBERT
IPC: C07C217/32
Filed: 1985-04-01
Abstract: New salts of alprenolol useful in treatment of cardiac disorders are the salts with benzoic acid and maleic acid.
Patent IL-62152-A0 (IL)
Title: Indane derivatives,pharmalceutical compositions and methods of preparation
IPC: C07D295/10
Filed: 1981-02-18
Abstract: 1-Piperazino-3-phenylindane derivatives of the formula: 
<CHEM>
 wherein R<1>, R<2>, R<3> and R<4> are as defined in Claim 1, and their pharmaceutically acceptable acid addition salts. 
<??>The compounds are prepared by the usual methods for analogous compounds. 
<??>They have been found to have psychopharmacological and analgetic activity. 
<??>Pharmaceutical compositions containing the compounds have been disclosed.
Patent IL-85932-A0 (IL)
Title: Novel pyridyl and pyrimidyl derivatives
IPC: C07D213/80
Filed: 1988-03-30
Abstract: PCT No. PCT/SE88/00144 Sec. 371 Date Nov. 30, 1988 Sec. 102(e) Date Nov. 30, 1988 PCT Filed Mar. 25, 1988 PCT Pub. No. WO88/07528 PCT Pub. Date Oct. 6, 1988.A compound having the formula (I) or a pharmaceutically acceptable salt thereof:  <IMAGE>  wherein all the symbols are defined in the specification; having valuable pharmaceutical properties, useful for the treatment of mental disorders, such as psychoses, depression and anxiety.
Patent IL-96153-A0 (IL)
Title: Synthesis of perfluoroalkyl bromides
IPC: C07C19/14
Filed: 1990-10-29
Abstract: The invention relates to the preparation of perfluoroalkyl bromides or bromoperfluoroalkanes CnF2n+1-Br (n=1 to 20). A perfluoroalkanesulphonyl chloride CnF2n+1-SO2Cl is reacted with a compound of formula:   <IMAGE>   in which X represents a nitrogen or phosphorus atom and R1, R2, R3 and R4, which may be identical or different, each represent an optionally substituted hydrocarbon radical, it also being possible for one of these symbols to be a hydrogen atom.
Patent IL-97622-A0 (IL)
Title: Antibodies that inhibit growth of kaposi's sarcoma
IPC: C12P21/08
Filed: 1991-03-21
Abstract: The present invention involves the use of monoclonal antibodies specific for Oncostatin M to inhibit the growth potentiating effect of Oncostatin M on Kaposi's Sarcoma associated with AIDS. In particular neutralizing anti-Oncostatin M antibodies inhibit the growth of Kaposi's Sarcoma which is potentiated and maintained by Oncostatin M or a factor found in conditioned media of an HTLV-II transformed T cell line.
Patent AU-PN926596-A0 (AU)
Title: Valve timing system
IPC: F01L13/00
Filed: 1996-04-16
Abstract: A variable valve timing system applicable for varying the opening and closing cycle of the inlet and outlet valves of an internal combustion engine. The system comprises a cam follower and a cam which is rotated about the cam shaft to move the valve between its open and closed position. To vary the cycle of the opening and closing valves, a rotational means is connected to the cam follower to rotate the cam follower such that the cam follower and cam are out of alignment such that the cam lobe engages the contact surface at a higher point and hence earlier than if the cam follower and the cats are aligned. Therefore the valve is opened sooner and closed later, increasing the degrees of cycle for which the valve is open, for example, as the engine revolutions increase.
Patent AU-PP980399-A0 (AU)
Title: Method and apparatus for attaching building sheets
IPC: E04F13/08
Filed: 1999-04-16
Abstract: A batten ( 100 ) for mounting cladding sheets to a wall or frame, said batten comprising an elongate channel member having a pair of spaced apart side walls ( 120, 140 ) joined by an intermediate web ( 110 ), and a corresponding pair of mounting flanges ( 124, 145 ) spaced outwardly from the web ( 110 ) and extending laterally from the side walls ( 120, 140 ), adapted for connection to the cladding sheets ( 300 ), and the batten ( 100 ) being configured such that stress applied to the cladding sheets ( 300 ) in use results in preferential deformation of the batten.
Patent IL-103811-A0 (IL)
Title: Microorganisms with stabilized plasmids
IPC: C12N15/00
Filed: 1992-11-19
Abstract: Novel microorganisms with plasmids which are stable with respect to betaine utilisation are described. These novel microorganisms contain a) a hybrid plasmid having a DNA fragment which contains a genetic sequence which codes for the utilisation of betaines and b) a mutation in the chromosomal gene coding for betaine utilisation. <IMAGE>
Patent IL-106646-A0 (IL)
Title: Dna sequences which lead to the formation of polyfructans(levans),plasmids containing these dna sequences and the use of these plasmids for preparing transgenic plants
IPC: C12N15/82
Filed: 1993-08-10
Abstract: PCT No. PCT/EP93/02110 Sec. 371 Date Feb. 9, 1995 Sec. 102(e) Date Feb. 9, 1995 PCT Filed Aug. 9, 1993 PCT Pub. No. WO94/04692 PCT Pub. Date Mar. 3, 1994There are described DNA sequences, which lead to the formation of levans, plasmids containing these DNA sequences, as well as a process using these plasmids for preparing transgenic plants with levan accumulation.
Patent IL-108730-A0 (IL)
Title: Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IPC: A61P25/18
Filed: 1994-02-22
Abstract: Tricyclic benzazepines having the general formula nd  beta -marked carbon atoms is a cyclopentene, cyclohexene, furan, dihydrofuran, pyran, dihydropyran, thiophene, oxazole, pyrrole, pyrroline, tetrahydropyridine or dioxole ring, R1 is H or alkyl, R2 and R3 independently are H, alkoxy, halogen, nitro, cyano or hydroxy, or R2 and R3 together may form a furan, dihydrofuran, cyclopentene or dioxole ring and R4 is H, alkoxy, nitro, cyano, hydroxy or halogen, or a pharmaceutically acceptable salt thereof, are useful in treatment of certain disorders in the central nervous system, e.g., psychosis, pain, depression, sleep disturbances, dyskinesia, Parkinson's disease, stroke.
Patent IL-111295-A0 (IL)
Title: Process for the preparation of asymmetrically substituted triazines
IPC: B01J31/04
Filed: 1994-10-13
Abstract: PCT No. PCT/EP94/03331 Sec. 371 Date Mar. 29, 1996 Sec. 102(e) Date Mar. 29, 1996 PCT Filed Oct. 10, 1994 PCT Pub. No. WO95/11237 PCT Pub. Date Apr. 27, 1995A process for preparing asymmetrically substituted triazines of the formula I    <IMAGE>  I  where R1 is hydrogen, methyl or ethyl, R2 and R3 independently of one another are an unsubstituted or substituted hydrocarbon radical, by reaction of a cyanoguanidine of the formula II    <IMAGE>  II  with a carboxylic acid derivative in the presence of an alcohol of the formula III R2-OHIII,which comprises reacting a carboxylic acid ester of the formula IV R3-COOR4IV,where R3 has the abovementioned meaning and R4 is an unsubstituted or substituted hydrocarbon radical, in the presence of a base or of a carboxamide selected from the group consisting of N,N-dialkylformamide, N,N-dialkylacetamide and N-methylpyrrolidone and in the presence of a salt or of a salt-like compound of the elements magnesium, calcium, aluminum, zinc, copper, iron, cobalt, nickel or chromium, is described.
Patent IL-111719-A0 (IL)
Title: Substituted n-piperidino-pyrazole-3-carboxamides, their preparation and pharmaceutical compositions containing them
IPC: A61P25/18
Filed: 1994-11-21
Abstract: N-Piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyra zole-3-carboxamide of formula: <IMAGE> its salts and solvates are powerful antagonists of central cannabinoid receptors. They are prepared by reaction of a functional derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxyli c acid with 1-aminopiperidine and then optional salification.
Patent IL-114399-A0 (IL)
Title: Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
IPC: A61K9/52
Filed: 1995-06-29
Abstract: A delivery system is disclosed for delivering a fluid-sensitive beneficial agent such as a somatotropin, or an analogue or derivative thereof, to an animal such as a bovine. The delivery system comprises a wall that surrounds an internal compartment, said wall comprising a first wall section that limits the passage of fluid into the system and a second wall section that permits the passage of fluid into the system. The wall may further comprise an end cap which may include means for adapting the end cap for ultrasonic welding to the first wall section and means for maintaining the beneficial agent in contact with exit means. The compartment comprises a beneficial agent and an expandable means. The delivery system comprises exit means for delivering the beneficial agent to the animal. The exit means may include means for compensating for slight variations in the efflux rate of the beneficial agent and means for maintaining for a sufficient velocity or efflux rate of beneficial agent outward from the device while minimizing diffusion of fluids from the external environment back into the device.
Patent IL-121126-A0 (IL)
Title: Method of increasing expression of molecular chaperon by an eukarytic cell
IPC: A61K31/47
Filed: 1996-11-01
Abstract: A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.
Patent IL-131397-A0 (IL)
Title: Method for producing 5-aminomethyl-2-chloropyridines
IPC: C07B43/04
Filed: 1998-03-02
Abstract: PCT No. PCT/EP98/01163 Sec. 371 Date Sep. 10, 1999 Sec. 102(e) Date Sep. 10, 1999 PCT Filed Mar. 2, 1998 PCT Pub. No. WO98/41504 PCT Pub. Date Sep. 24, 1998The present invention relates to the preparation of 5-aminomethyl-2-chloropyridines by reacting a mixture of 5-chloromethyl-2-chloropyridine and 5-dichloromethyl-2-chloropyridine with substituted amines. The mixture of 5-chloromethyl-2-chloropyridine and 5-dichloromethyl-2-chloropyridine is obtained by chlorination of 5-methyl-2-chloropyridine.
Patent IL-143177-A0 (IL)
Title: Crystals of 5- [{6- (2-fluorobenzyl) oxy-2-naphthyl} methyl]-2,4-thiazolidinedione
IPC: A61P3/10
Filed: 1999-11-19
Abstract: The invention relates to type A crystal of 5-[{6-(2-fluorobenzyl)oxy-2-naphtyl}methyl]-2,4-thiazolidinedione characterized to have characteristic absorption peaks (2theta) at 11.5°±0.3°, 14.5°±0.2°, 16.2°±0.3°, 17.0°±0.3°, 17.7°±0.2°, 18.6°±0.3°, 19.1°±0.2°, 21.3°±0.4°, 22.4°±0.5°, 25.7°±1.5° and 28.3°±10.5° in a powder X-ray diffraction pattern, and also to a method for preparation thereof, and a pharmaceutical composition comprising the same. The crystal is excellent in stability, and has advantages in handling, storage, and pharmaceutical preparation. The invention also relates to type B, C and D crystals of said compound.
Patent IL-145992-A0 (IL)
Title: Method for the encoding of prosody for a speech encoder working at very low bit rates
IPC: G10L15/10
Filed: 2001-10-17
Abstract: The speech coding decoding system has a step of learning to identify speech signal representatives and a coding step segmenting the speech signals, and determining the best associated representation. There is a step of coding/decoding of one parameter from the recognised information segment set which is the best representation of energy or pitch and/or closeness and/ or segment length.
Patent IL-148249-A0 (IL)
Title: Method and holding device for a cutting tool
IPC: B23B27/16
Filed: 2000-09-01
Abstract: A method and holding device for locking an insert into a tool are used in metal removal machining. The tool includes an insert (2) with a upper contact surface or section (4) and a lower contact surface of section (6) and a holder (8) in which the insert (2) is arranged. The holder includes a holder body (10) and a clamping device (12). The holder body has a lower contact surface or section (14). The insert is arranged in the holder such that the upper contact surface or section (4) of the insert is brought into contact and interaction with a bottom surface (16) of a clamping device while the lower contact surface or section (6) of the insert is brought into contact and interaction with the lower contact surface or section (14) of the holder. At least one of the contact surfaces (4, 6) of the insert (2) includes protrusions (20) in the form of rounded cones, teeth or the like, that are pressed, at least partially, into the surface (14, 16) of the opposite holder and to deform the surface of the holder when the insert is arranged and subject to load in the holder (8).
Patent IL-149788-A0 (IL)
Title: Production of vaccines
IPC: C12N15/34
Filed: 2000-11-24
Abstract: Novel means and methods are provided for the production of mammalian viruses, comprising infecting a culture of immortalized human cells with the virus, incubating the culture infected with virus to propagate the virus under conditions that permit growth of the virus, and to form a virus-containing medium, and removing the virus-containing medium. <??>The viruses can be harvested and be used for the production of vaccines. <??>Advantages - human cells of the present invention can be cultured under defined serum free conditions, and the cells show improved capability for propagating virus. <??>In particular, methods are provided for producing in cultured human cells Influenza virus and vaccines derived thereof. This method eliminates the necessity to use whole chicken embryos for the production of Influenza vaccines. <??>The method provides also for the continuous or batchwise removal of culture media. As such, the present invention allows the large scale continuous production of viruses to a high titer.
Patent IL-162860-A0 (IL)
Title: Sedative non-benzodiazepine formulations
IPC: A61K9/20
Filed: 2003-01-09
Abstract: The invention provides for an enhanced absorption pharmaceutical composition comprising a plurality of microparticles, each microparticle comprising at least one sedative non-benzodiazepine, at least one spheronization aid and at least one solubility enhancer. The microparticles of the invention are further incorporated into an oral fast-dispersing dosage form.